Skip to content
Screener

HealthEquity HQY Allowance for Doubtful Accounts Receivable (Current)

Allowance for Doubtful Accounts Receivable (Current) at other companies

WEX logo
WEXWEX
$93.2M+11.4%
CVS Health logo
CVS HealthCVS
$169M
CareCloud, Inc. logo
CareCloud, Inc.CCLD
$948K+8.3%
CBIZ logo
CBIZCBZ
$50.09M+14.8%
Oscar Health logo
Oscar HealthOSCR
$55.3M

Other financials

Income statement

See full
Revenue$354.6M+7.2%
Gross profit$256.3M+14.3%
Operating income$103.0M+23.9%
Net income$69.4M+28.8%
EPS (diluted)$0.82+34.4%

Balance sheet

See full
Cash & equivalents$265.4M-7.8%
Total debt$984.7M-11.0%
Total equity$2.0B-3.6%
Total assets$3.3B-3.2%

Cash flow

See full
Operating cash flow$97.5M+50.6%
CapEx$362.0K+321%
Free cash flow$97.2M+50.3%

Valuation

See full
Market cap$8.93B+11.7%
Enterprise value$9.65B+10.3%
P/E38.7×-16.1×
P/S6.7×+0.4×

Profitability

See full
Gross margin70.7%+5.2pp
Operating margin25.6%+9.2pp
Net margin17.3%+7.5pp
FCF margin36.5%+9.3pp

Returns & leverage

See full
Return on equity11.1%+5.3pp
Debt / equity0.5×0.0×
Current ratio3.4×-0.6×

Where this comes from

Reported directly by HealthEquity in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The source filing: HealthEquity’s 10-Q, filed May 28, 2026.

Filed
May 28, 2026, 4:04 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001428336-26-000028
(in thousands, except par value)April 30, 2026January 31, 2026
Assets
Current assets
Cash and cash equivalents$265,369$318,927
Accounts receivable, net of allowance for doubtful accounts of $953 and $924 as of April 30, 2026 and January 31, 2026, respectively122,003123,696
Prepaid expenses and other current assets79,15669,658
Total current assets466,528512,281
Property and equipment, net3,8003,177
Operating lease right-of-use assets34,57836,310

Item 1. Financial statements

FAQ

What is HealthEquity's allowance for doubtful accounts receivable (current)?
HealthEquity (HQY) reported allowance for doubtful accounts receivable (current) of $953K in Q1 2026.
How has HealthEquity's allowance for doubtful accounts receivable (current) changed year-over-year?
HealthEquity's allowance for doubtful accounts receivable (current) decreased by 8.5% year-over-year, from $1.04M to $953K.
What is the long-term trend for HealthEquity's allowance for doubtful accounts receivable (current)?
Over 5 years (2021 to 2026), HealthEquity's allowance for doubtful accounts receivable (current) has grown at a -26.3% compound annual growth rate (CAGR), from $4.24M to $924K.
What does allowance for doubtful accounts receivable (current) mean?
This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.

Ask your AI about HealthEquity's allowance for doubtful accounts receivable (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude